Sweden has a tax-financed health care system that provides a uniform system for lung cancer diagnostics and treatment across geographic areas, socioeconomic-, and age groups (e.g. there are no additional costs or need for private insurance for the individual patient for PD-L1 testing or treatment). The gene discussed is CD274; the disease is lung cancer.